Skip to Content
Merck
All Photos(1)

Documents

T0682

Sigma-Aldrich

Sodium taurohyodeoxycholate hydrate

≥98%

Synonym(s):

Taurohyodeoxycholic acid sodium salt hydrate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
C26H44NO6SNa · xH2O
CAS Number:
38411-85-7
Molecular Weight:
521.69 (anhydrous basis)
MDL number:
MFCD09263185
UNSPSC Code:
12161900
PubChem Substance ID:
24899908
NACRES:
NA.25

description

anionic

Quality Level

100

Assay

≥98%

mol wt

521.69 g/mol (anhydrous basis)

application(s)

detection

SMILES string

O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

1S/C26H45NO6S.Na.H2O/c1-16(4-7-24(30)27-12-13-34(31,32)33)19-5-6-20-18-15-23(29)22-14-17(28)8-10-26(22,3)21(18)9-11-25(19,20)2;;/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);;1H2/q;+1;/p-1/t16-,17-,18+,19-,20+,21+,22+,23+,25-,26-;;/m1../s1

InChI key

MJKUJELEPWZEGU-IGEKTTBWSA-M

Related Categories

General description

Sodium taurohyodeoxycholate hydrate is a taurine-amidated bile salt, which can be used as an anionic detergent.

Application

Sodium taurohyodeoxycholate hydrate has been used in a study to assess dose-response data for cytotoxicity, regenerative cell proliferation and secondary oxidative DNA damage in rat livers treated with furan. It has also been used in a study to investigate the use of an immobilized artificial membrane HPLC column to predict bile salt-membrane interactions.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 8

1 of 8

Taurodeoxycholic Acid, Sodium Salt Detergent useful for the solubilization of lipids and membrane-bound proteins. Aggregation number: 6.

Millipore

580221

Taurodeoxycholic Acid, Sodium Salt

≥95% (HPLC)

Sigma-Aldrich

T4009

Taurocholic acid sodium salt hydrate

Sodium glycochenodeoxycholate

Sigma-Aldrich

G0759

Sodium glycochenodeoxycholate

≥98% (HPLC)

Sigma-Aldrich

SML0309

Sodium phenylbutyrate

synthetic, ≥97% (HPLC)

Sigma-Aldrich

G2878

Glycocholic acid hydrate

99%

Sigma-Aldrich

P21005

4-Phenylbutyric acid

from bovine and/or ovine, ≥98%

Sigma-Aldrich

C1129

Cholic acid

Sodium taurocholate hydrate ≥97.0% (TLC)

Sigma-Aldrich

86339

Sodium taurocholate hydrate

K J Van Erpecum et al.
European journal of clinical investigation, 26(7), 602-608 (1996-07-01)
Precipitation of cholesterol crystals is an essential step in gallstone formation. In the present study we found much faster and more extensive precipitation of various cholesterol crystal shapes in whole model biles containing the hydrophobic bile salt taurodeoxycholate than in
Francesca Carubbi et al.
Biochimica et biophysica acta, 1580(1), 31-39 (2002-03-30)
This study was performed to compare the effects of two hydrophilic bile acids, taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA), on HepG2 cells. Cytotoxicity was evaluated at different times of exposure by incubating cells with increasing concentrations (50-800 micromol/l) of
P Loria et al.
Hepatology (Baltimore, Md.), 25(6), 1306-1314 (1997-06-01)
This study aimed to determine the effect in humans of taurohyodeoxycholic acid, a 6alpha-hydroxylated bile acid with hydrophilic properties, on bile lipid secretion. Four cholecystectomized patients who had gallstones and an interrupted enterohepatic circulation were intraduodenally infused with taurohyodeoxycholic and
F Feletti et al.
Arzneimittel-Forschung, 43(8), 894-897 (1993-08-01)
The reproductive toxicity of taurohyodeoxycholic acid (3 alpha, 6 alpha-dihydroxy-5-beta-cholanoyl-2-amino-ethyl-sulfonic acid, THDCA, Io, Praxis, CAS 2958-04-5), a new synthetized biliary acid patented in Europe, Japan and the United States for prevention and therapy of gallstones and related symptoms, was assayed
M Paolini et al.
Hepatology (Baltimore, Md.), 30(3), 730-739 (1999-08-26)
We examined the effects of the administration of different bile acids on in vivo hepatic murine cytochrome P450 (CYP) content, nicotinamide adenine dinucleotide phosphate (NADPH)-CYP-reductase, and individual mixed-function oxidases (MFOs). Neither CYP level nor reductase were appreciably affected by single
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service